Close

Mene Pangalos elected to the Fellowship of the Academy of Medical Sciences

Related stories

Cancer Diagnostics Market Outlook 2031: Growth Trends and Insights

The global cancer diagnostics market, valued at USD 163.7 billion...

Trends and Challenges to Face the Pharma Industry in 2024

The Clinical Research Organisation (CRO) sector is set for...

AAV Therapy Collaboration Amidst $2.57B CDMO Market Surge

The global market for cell and gene therapy biomanufacturing...

Syntegon with stable business development in 2022

Syntegon looks back on a stable business development in...

The Importance of Relationships in the Rare Disease Community

In my role as CRO Partner Manager, I’m responsible...

IMED leader one of 48 new fellows recognised for the advancement of medical science in the UK

Each year the Academy of Medical Sciences elect a small number of UK scientists to their Fellowship in recognition of their contribution to the advancement of medical science. Potential Academy Fellows are nominated for election based on their excellence in medical research, their innovative application of scientific knowledge or for their service to healthcare.

Earlier today, it was announced that Mene Pangalos, Executive Vice President of our Innovative Medicines and Early Development Biotech Unit, has been elected as one of just 48 new Fellows – out of more than 350 nominations.

On hearing the news, Mene commented: “It’s a great honour to be elected as a Fellow of the Academy of Medical Sciences. I am looking forward to working with the Fellowship to drive greater connections between academia, industry and the NHS and to develop new ways to inspire the next generation of UK scientists.”

 

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Latest stories